Artículos de revistas
Recommendations by the scientific department of neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for treatment and research in multiple sclerosis and neuroimmunological diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous system
Recomendações do Departamento Científico de Neuroimunologia da Academia Brasileira de Neurologia (DCNI/ABN) e do Comitê Brasileiro de Tratamento e Pesquisa em Esclerose Múltipla e Doenças Neuroimunológicas (BCTRIMS) sobre vacinação em geral e contra a SARS-CoV-2 para pacientes com doenças desmielinizantes do sistema nervoso central
Fecha
2021-11-01Registro en:
Arquivos de Neuro-Psiquiatria, v. 79, n. 11, p. 1049-1061, 2021.
1678-4227
0004-282X
10.1590/0004-282X-ANP-2021-0162
2-s2.0-85120704935
Autor
Pontifícia Universidade Católica Do Rio Grande Do Sul
Universidade Federal de Sergipe (UFS)
Universidade Tiradentes
Universidade Estadual de Campinas (UNICAMP)
Universidade Federal de São Paulo (UNIFESP)
Universidade Federal de Minas Gerais (UFMG)
Universidade de São Paulo (USP)
Universidade Federal Do Amazonas
Universidade Federal do Paraná (UFPR)
Hospital Sírio Libanês
Escola Bahiana de Medicina e Saúde Pública
Hospital Geral de Fortaleza
Clínica Nossa Senhora das Graças
Hospital Santa Marcelina
Santa Casa
Instituto de Infectologia Emílio Ribas
Fundação Centro Integrado de Apoio Ao Portador de Deficiência
Secretaria de Estado da Saúde
Universidade Federal do Rio de Janeiro (UFRJ)
Hospital de Clínicas de Passo Fundo
Universidade Federal de Goiás (UFG)
Universidade Estácio de Sá
Hospital São Francisco Na Providência de Deus
Universidade Federal Do Ceará
Associação Brasileira de Esclerose Múltipla
Universidade Federal Fluminense (UFF)
Pontifícia Universidade Católica
Instituto de Neurologia de Curitiba
IAMSPE
Private Service
Universidade da Região de Joinville
Hospital Moinhos de Vento
Universidade Federal Ciências da Saúde de Porto Alegre
Faculdade de Medicina de Jundiaí
Hospital Israelita Albert Einstein
Hospital de Base Do Distrito Federal
Hospital Beneficiência Portuguesa
Hospital Regional de Vilhena
Universidade Federal Do Estado Do Rio de Janeiro
Hospital Universitário Prof. Edgar Santos
Universidade Metropolitana de Santos
Hospital da Restauração
Universidade Estadual Paulista (UNESP)
Universidade de Brasília (UnB)
Institución
Resumen
The Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) provide recommendations in this document for vaccination of the population with demyelinating diseases of the central nervous system (CNS) against infections in general and against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. We emphasize the seriousness of the current situation in view of the spread of COVID-19 in our country. Therefore, reference guides on vaccination for clinicians, patients, and public health authorities are particularly important to prevent some infectious diseases. The DCNI/ABN and BCTRIMS recommend that patients with CNS demyelinating diseases (e.g., MS and NMOSD) be continually monitored for updates to their vaccination schedule, especially at the beginning or before a change in treatment with a disease modifying drug (DMD). It is also important to note that vaccines are safe, and physicians should encourage their use in all patients. Clearly, special care should be taken when live attenuated viruses are involved. Finally, it is important for physicians to verify which DMD the patient is receiving and when the last dose was taken, as each drug may affect the induction of immune response differently.